Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Nov-24 4:05 PM View:  | Aastrom Biosciences, Inc. (VCEL) | 13-Nov-24 | Option Exercise | 7,000 | $3.74 | $26,180.00 | 59% 11.9K to 18.9K | |
| 15-Nov-24 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 13-Nov-24 | Option Sale | 7,000 | $55.54 | $388,780.00 | (37%) 18.9K to 11.9K | |
| 09-Aug-24 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 07-Aug-24 | Option Exercise | 7,000 | $3.74 | $26,180.00 | 59% 11.9K to 18.9K | |
| 09-Aug-24 4:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 07-Aug-24 | Option Sale | 7,000 | $45.94 | $321,580.00 | (37%) 18.9K to 11.9K | |
| 03-May-24 4:06 PM View: | Aastrom Biosciences, Inc. (VCEL) | 01-May-24 | Option Exercise | 3,200 | -- | -- | 37% 8.7K to 11.9K | |
| 25-Sep-23 4:28 PM View: | Decibel Therapeutics, Inc. (DBTX) | 25-Sep-23 | Disposition | 5,000 | -- | -- | (100%) 5.0K to 0 | |
| 14-Jun-23 4:37 PM View: | Decibel Therapeutics, Inc. (DBTX) | 13-Jun-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 28-Apr-23 4:04 PM View: | Aastrom Biosciences, Inc. (VCEL) | 27-Apr-23 | Option Exercise | 2,600 | -- | -- | 43% 6.1K to 8.7K | |
| 29-Apr-22 4:10 PM View: | Aastrom Biosciences, Inc. (VCEL) | 27-Apr-22 | Option Exercise | 2,600 | -- | -- | 74% 3.5K to 6.1K | |
| 22-Nov-21 9:03 AM View: | Acceleron Pharma Inc (XLRN) | 19-Nov-21 | Disposition (change in control) | 10,681 | -- | -- | (100%) 10.68K to 0 | |
| 24-Sep-21 10:00 PM View: | Acceleron Pharma Inc (XLRN) | 24-Sep-21 | Option Exercise | 5,370 | $40.64 | $218,251.00 | 50% 10.68K to 16.05K | |
| 24-Sep-21 10:00 PM View: | Acceleron Pharma Inc (XLRN) | 24-Sep-21 | Market Option Sale (Planned) | 5,370 | $160.38 | $861,241.00 | (33%) 16.05K to 10.68K | (12%) |
| 24-Sep-21 10:00 PM View: | Acceleron Pharma Inc (XLRN) | 23-Sep-21 | Option Exercise | 19,630 | $39.67 | $778,624.00 | 184% 10.68K to 30.31K | |
| 24-Sep-21 10:00 PM View: | Acceleron Pharma Inc (XLRN) | 23-Sep-21 | Market Option Sale (Planned) | 19,630 | $160.31 | $3,146,890.00 | (65%) 30.31K to 10.68K | (12%) |
| 30-Apr-21 4:09 PM View: | Aastrom Biosciences, Inc. (VCEL) | 28-Apr-21 | Option Exercise | 1,750 | -- | -- | 100% 1.75K to 3.5K | |
| 02-Feb-21 7:46 PM View: | Acceleron Pharma Inc (XLRN) | 29-Jan-21 | Grant | 4,868 | -- | -- | 84% 5.81K to 10.68K | |
| 06-Jan-21 7:03 PM View: | Acceleron Pharma Inc (XLRN) | 05-Jan-21 | Market Sale (Planned) | 1,499 | $121.40 | $181,982.00 | (21%) 7.31K to 5.81K | (48%) |
| 06-Jan-21 7:03 PM View: | Acceleron Pharma Inc (XLRN) | 04-Jan-21 | Payment of Exercise | 624 | $124.31 | $77,569.40 | (6%) 11.22K to 10.59K | (45%) |
| 06-Jan-21 7:03 PM View: | Acceleron Pharma Inc (XLRN) | 04-Jan-21 | Market Sale (Planned) | 3,280 | $124.08 | $406,992.00 | (31%) 10.59K to 7.31K | (45%) |
| 15-Dec-20 6:24 PM View: | Acceleron Pharma Inc (XLRN) | 14-Dec-20 | Option Exercise | 42,528 | $32.29 | $1,373,160.00 | 379% 11.22K to 53.74K | |
| 15-Dec-20 6:24 PM View: | Acceleron Pharma Inc (XLRN) | 14-Dec-20 | Market Option Sale (Planned) | 42,528 | $130.14 | $5,534,590.00 | (79%) 53.74K to 11.22K | (38%) |
| 11-Dec-20 6:08 PM View: | Acceleron Pharma Inc (XLRN) | 11-Dec-20 | Option Exercise | 3,100 | $41.20 | $127,720.00 | 28% 11.22K to 14.32K | |
| 11-Dec-20 6:08 PM View: | Acceleron Pharma Inc (XLRN) | 11-Dec-20 | Market Option Sale (Planned) | 3,100 | $125.00 | $387,500.00 | (22%) 14.32K to 11.22K | (44%) |
| 11-Dec-20 6:08 PM View: | Acceleron Pharma Inc (XLRN) | 10-Dec-20 | Option Exercise | 500 | $33.58 | $16,792.00 | 4% 11.22K to 11.72K | |
| 11-Dec-20 6:08 PM View: | Acceleron Pharma Inc (XLRN) | 10-Dec-20 | Market Option Sale (Planned) | 500 | $125.12 | $62,560.00 | (4%) 11.72K to 11.22K | (44%) |
| 11-Dec-20 6:08 PM View: | Acceleron Pharma Inc (XLRN) | 09-Dec-20 | Option Exercise | 3,872 | $36.55 | $141,537.00 | 35% 11.22K to 15.09K | 5% |
| 11-Dec-20 6:08 PM View: | Acceleron Pharma Inc (XLRN) | 09-Dec-20 | Market Option Sale (Planned) | 3,872 | $125.03 | $484,116.00 | (26%) 15.09K to 11.22K | (44%) |
| 01-May-20 4:13 PM View: | Aastrom Biosciences, Inc. (VCEL) | 29-Apr-20 | Option Exercise | 1,750 | -- | -- | 100% 0 to 1.75K | |
| 10-Apr-20 5:29 PM View: | Acceleron Pharma Inc (XLRN) | 09-Apr-20 | Option Exercise | 17,226 | $41.20 | $709,711.00 | 154% 11.22K to 28.44K | |
| 10-Apr-20 5:29 PM View: | Acceleron Pharma Inc (XLRN) | 09-Apr-20 | Market Option Sale (Planned) | 17,226 | $88.19 | $1,519,160.00 | (61%) 28.44K to 11.22K | (104%) |
| 10-Apr-20 5:29 PM View: | Acceleron Pharma Inc (XLRN) | 08-Apr-20 | Option Exercise | 36,774 | $32.74 | $1,204,130.00 | 328% 11.22K to 47.99K | |
| 10-Apr-20 5:29 PM View: | Acceleron Pharma Inc (XLRN) | 08-Apr-20 | Market Option Sale (Planned) | 36,774 | $85.51 | $3,144,610.00 | (77%) 47.99K to 11.22K | (110%) |
| 24-Jan-20 5:21 PM View: | Acceleron Pharma Inc (XLRN) | 22-Jan-20 | Grant | 6,369 | -- | -- | 131% 4.85K to 11.22K | |
| 03-Jan-20 9:41 PM View: | Acceleron Pharma Inc (XLRN) | 02-Jan-20 | Market Sale (Planned) | 5,579 | $52.50 | $292,923.00 | (54%) 10.43K to 4.85K | (242%) |
| 17-Dec-19 6:39 PM View: | Acceleron Pharma Inc (XLRN) | 13-Dec-19 | Market Sale (Planned) | 11,853 | $50.28 | $595,969.00 | (53%) 22.28K to 10.43K | (257%) |
| 10-Sep-19 8:22 PM View: | Acceleron Pharma Inc (XLRN) | 10-Sep-19 | Market Sale (Planned) | 8,000 | $45.30 | $362,400.00 | (26%) 30.28K to 22.28K | (297%) |
| 11-Apr-19 4:58 PM View: | Acceleron Pharma Inc (XLRN) | 09-Apr-19 | Market Sale (Planned) | 12,000 | $44.62 | $535,405.00 | (28%) 42.28K to 30.28K | (303%) |
| 04-Apr-19 6:07 PM View: | Acceleron Pharma Inc (XLRN) | 02-Apr-19 | Market Sale (Planned) | 648 | $48.02 | $31,117.00 | (2%) 42.93K to 42.28K | (274%) |
| 29-Jan-19 5:38 PM View: | Acceleron Pharma Inc (XLRN) | 25-Jan-19 | Grant | 4,700 | -- | -- | 12% 38.23K to 42.93K | |
| 04-Jan-19 6:34 PM View: | Acceleron Pharma Inc (XLRN) | 02-Jan-19 | Market Sale (Planned) | 5,712 | $42.80 | $244,494.00 | (13%) 43.94K to 38.23K | (320%) |
| 31-Aug-18 7:00 PM View: | Acceleron Pharma Inc (XLRN) | 30-Aug-18 | Option Exercise | 12,500 | $27.97 | $349,625.00 | 28% 43.94K to 56.44K | |
| 31-Aug-18 7:00 PM View: | Acceleron Pharma Inc (XLRN) | 30-Aug-18 | Market Option Sale (Planned) | 12,500 | $54.00 | $675,000.00 | (22%) 56.44K to 43.94K | (233%) |
| 03-Jul-18 2:32 PM View: | Acceleron Pharma Inc (XLRN) | 29-Jun-18 | Option Exercise | 25,000 | $24.11 | $602,750.00 | 57% 43.94K to 68.94K | |
| 03-Jul-18 2:32 PM View: | Acceleron Pharma Inc (XLRN) | 29-Jun-18 | Market Option Sale (Planned) | 25,000 | $48.00 | $1,200,000.00 | (36%) 68.94K to 43.94K | (274%) |
| 04-Apr-18 4:38 PM View: | Acceleron Pharma Inc (XLRN) | 03-Apr-18 | Market Sale (Planned) | 4,000 | $38.45 | $153,792.00 | (8%) 47.94K to 43.94K | (367%) |
| 05-Mar-18 5:14 PM View: | Acceleron Pharma Inc (XLRN) | 01-Mar-18 | Grant | 5,138 | -- | -- | 12% 42.8K to 47.94K | |
| 04-Jan-18 7:03 PM View: | Acceleron Pharma Inc (XLRN) | 04-Jan-18 | Market Option Sale (Planned) | 8,501 | $43.01 | $365,638.00 | (15%) 57.8K to 49.3K | (318%) |
| 04-Jan-18 7:03 PM View: | Acceleron Pharma Inc (XLRN) | 04-Jan-18 | Market Sale (Planned) | 6,499 | $43.01 | $279,530.00 | (13%) 49.3K to 42.8K | (318%) |
| 04-Jan-18 7:03 PM View: | Acceleron Pharma Inc (XLRN) | 03-Jan-18 | Option Exercise | 12,501 | $4.58 | $57,253.90 | 28% 45.3K to 57.8K | |
| 04-Jan-18 7:03 PM View: | Acceleron Pharma Inc (XLRN) | 02-Jan-18 | Market Option Sale (Planned) | 4,000 | $42.42 | $169,680.00 | (8%) 49.3K to 45.3K | (324%) |